Akela Pharma, Inc. (AKL.TO) -Toronto
|1y Target Est:||N/A|
|Next Earnings Date:||N/A|
|Day's Range:||N/A - N/A|
|52wk Range:||0.01 - 0.15|
|Avg Vol (3m):||N/A|
|Div & Yield:||N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in .
- No Headlines available for AKL.TO at this time.
|Forward P/E (1 yr):||N/A|
|Annual EPS Est
|Quarterly EPS Est
|PEG Ratio (5 yr expected):||N/A|
Akela Pharma, Inc. operates as a specialty contract pharmaceutical formulation developer in the United States. It offers contract pharma services comprising formulation and process development of drug in tablets, capsules, multiparticulates, fast ... View More